BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37411022)

  • 21. Methods for managing miscarriage: a network meta-analysis.
    Ghosh J; Papadopoulou A; Devall AJ; Jeffery HC; Beeson LE; Do V; Price MJ; Tobias A; Tunçalp Ö; Lavelanet A; Gülmezoglu AM; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD012602. PubMed ID: 34061352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion.
    Kapp N; Mao B; Menzel J; Eckersberger E; Saphonn V; Rathavy T; Pearson E
    BMJ Sex Reprod Health; 2023 Oct; 49(4):300-307. PubMed ID: 36894309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accounting for Misclassification and Selection Bias in Estimating Effectiveness of Self-managed Medication Abortion.
    Jayaweera RT; Bradshaw PT; Gerdts C; Egwuatu I; Grosso B; Kristianingrum I; Nmezi S; Zurbriggen R; Ahern J; Moseson H
    Epidemiology; 2023 Jan; 34(1):140-149. PubMed ID: 36455250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers to abortion care and incidence of attempted self-managed abortion among individuals searching Google for abortion care: A national prospective study.
    Upadhyay UD; Cartwright AF; Grossman D
    Contraception; 2022 Feb; 106():49-56. PubMed ID: 34560051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expulsion at home for early medical abortion: A systematic review with meta-analyses.
    Schmidt-Hansen M; Pandey A; Lohr PA; Nevill M; Taylor P; Hasler E; Cameron S
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):727-735. PubMed ID: 33063314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
    Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E
    Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women's self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria.
    Stillman M; Owolabi O; Fatusi AO; Akinyemi AI; Berry AL; Erinfolami TP; Olagunju OS; Väisänen H; Bankole A
    BMJ Open; 2020 May; 10(5):e034670. PubMed ID: 32376752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical methods for first trimester abortion.
    Kulier R; Kapp N; Gülmezoglu AM; Hofmeyr GJ; Cheng L; Campana A
    Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD002855. PubMed ID: 22071804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial.
    Shaw KA; Shaw JG; Hugin M; Velasquez G; Hopkins FW; Blumenthal PD
    Contraception; 2015 Apr; 91(4):313-9. PubMed ID: 25499589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation.
    Hsia JK; Lohr PA; Taylor J; Creinin MD
    Contraception; 2019 Sep; 100(3):178-181. PubMed ID: 31102629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan.
    Platais I; Tsereteli T; Grebennikova G; Lotarevich T; Winikoff B
    Int J Gynaecol Obstet; 2016 Sep; 134(3):268-71. PubMed ID: 27352735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy.
    Podolskyi V; Gemzell-Danielsson K; Maltzman LL; Marions L
    Acta Obstet Gynecol Scand; 2023 May; 102(5):541-548. PubMed ID: 36933004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.
    Young D; Fitzgerald K; Laursen L; Whitaker AK
    Contraception; 2022 Nov; 115():62-66. PubMed ID: 35772525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone Compared With Overnight Osmotic Dilators Alone: A Randomized Controlled Trial.
    Goldberg AB; Fortin JA; Drey EA; Dean G; Lichtenberg ES; Bednarek PH; Chen BA; Dutton C; McKetta S; Maurer R; Winikoff B; Fitzmaurice GM
    Obstet Gynecol; 2015 Sep; 126(3):599-609. PubMed ID: 26196084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
    Anger HA; Raymond EG
    Contraception; 2023 Aug; 124():110055. PubMed ID: 37088124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.